Aerosol therapy: The special needs of young children

Paediatric Respiratory Reviews

Volumn 7, Issue SUPPL. 1, 2006, Pages

  Janssens, Hettie M ^a   Tiddens, Harm A W M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

aerosol; asthma; children; face mask; lung deposition; spacer; therapy

Indexed keywords

ACETYLCYSTEINE; ANTIASTHMATIC AGENT; BECLOMETASONE; BRONCHODILATING AGENT; COLISTIN; DORNASE ALFA; SODIUM CHLORIDE; STEROID; TOBRAMYCIN;

ASTHMA; CHILD; CHILDHOOD DISEASE; COOPERATION; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; FACE MASK; HUMAN; INDIVIDUALIZATION; INHALATION SPACER; LUNG DEPOSIT; MAINTENANCE THERAPY; METERED DOSE INHALER; MOUTH BREATHING; NEBULIZER; NOSE BREATHING; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ADMINISTRATION, INHALATION; AEROSOLS; ASTHMA; CHILD; EQUIPMENT DESIGN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NEBULIZERS AND VAPORIZERS; PRESCRIPTIONS, DRUG;

EID: 33745208693     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.167     Document Type: Review

References (26)

1. Janssens H.M., Heijnen E.M., de Jong V.M., Hop W.C., Holland W.P., de Jongste J.C., et al. Aerosol delivery from spacers in wheezy infants: a daily life study. Eur Respir J 16 (2000) 850-856
2. Amirav I., Newhouse M.T., and Mansour Y. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma. Pediatr Pulmonol 39 (2005) 447-451
3. Nielsen K.G., Skov M., Klug B., Ifversen M., and Bisgaard H. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer. Eur Respir J 10 (1997) 2105-2109
4. Ross D.L., and Schultz R.K. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products. J Aerosol Med 9 (1996) 215-226
5. Tiddens H. Matching the device to the patient. Pediatr Pulmonol Suppl 26 (2004) 26-29
6. Chua H.L., Collis G.G., Newbury A.M., Chan K., Bower G.D., Sly P.D., et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 7 (1994) 2185-2191
7. Everard M.L., Clark A.R., and Milner A.D. Drug delivery from jet nebulisers. Arch Dis Child 67 (1992) 586-591
8. Cates C.J., and Rowe B.H. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev (2000) 7
9. Newman S.P., Millar A.B., Lennard-Jones T.R., Moren F., and Clarke S.W. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax 39 (1984) 935-941
10. Amirav I., and Newhouse M. Delivery of aerosols to children with MDI and holding chambers (MHC) is critically dependent on the facemask seal. Am J Resp Crit Care Med 159 (1999) A142
11. Esposito-Festen J.E., Ates B., van Vliet F.J., Verbraak A.F., de Jongste J.C., and Tiddens H.A. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J Aerosol Med 17 (2004) 1-6
12. Amirav I., and Newhouse M.T. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics 108 (2001) 389-394
13. Esposito-Festen J., Ates B., van Vliet F., Hop W., and Tiddens H. Aerosol delivery to young children by pMDI-spacer: is facemask design important?. Pediatr Allergy Immunol 16 (2005) 348-353
14. Hayden J.T., Smith N., Woolf D.A., Barry P.W., and O'Callaghan C. A randomised crossover trial of facemask efficacy. Arch Dis Child 89 (2004) 72-73
15. Smaldone G.C., Berg E., and Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med 18 (2005) 354-363
16. Barry P.W., and O'Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol 40 (1995) 76-78
17. Wildhaber J.H., Devadason S.G., Hayden M.J., James R., Dufty A.P., Fox R.A., et al. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J 9 (1996) 1943-1946
18. Pierart F., Wildhaber J.H., Vrancken I., Devadason S.G., and Le Souef P.N. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 13 (1999) 673-678
19. Wildhaber J.H., Janssens H.M., Pierart F., Dore N.D., Devadason S.G., and LeSouef P.N. High-percentage lung delivery in children from detergent-treated spacers. Pediatr Pulmonol 29 (2000) 389-393
20. Janssens H.M., Krijgsman A., Verbraak T.F., Hop W.C., de Jongste J.C., and Tiddens H.A. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model. J Aerosol Med 17 (2004) 51-61
21. Janssens H.M., De Jongste J.C., Hop W.C., and Tiddens H.A. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest 123 (2003) 2083-2088
22. 99mTc-labelled Qvar delivered using an Autohaler™ device in children. Eur Resp J 21 (2003) 1007-1011
23. Iles R., Lister P., and Edmunds A.T. Crying significantly reduces absorption of aerosolised drug in infants. Arch Dis Child 81 (1999) 163-165
24. Tal A., Golan H., Grauer N., Aviram M., Albin D., and Quastel M.R. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 128 (1996) 479-484
25. Janssens H.M., van der Wiel E.C., Verbraak A.F., de Jongste J.C., Merkus P.J., and Tiddens H.A. Aerosol therapy and the fighting toddler: is administration during sleep an alternative?. J Aerosol Med 16 (2003) 395-400
26. Esposito Festen JE, Ijsselstijn H, Hop WCJ, van Vliet FJM, de Jongste JC, Tiddens HAWM. Aerosol therapy by pMDI-spacer in sleeping young children: to do or not to do? Chest 2006 (In press).